Abstract
Introduction
Recently catapulted into the pharmaceutical industry limelight, Specialty
Pharma may well be the solution to many of Big Pharma' s current woes. Its
success driven largely by astute manipulation of the business and market
issues that currently plague Big Pharma, Specialty Pharma has shown the
potential to capture and fi rmly command market spaces once dominated by Big
Pharma.
Get the Answers You Need to Shape Your Strategy
- The emergence of Specialty Pharma as a market force occurred as Big Pharma
and Mid Pharma began to consolidate. What strategies will Specialty Pharma
pursue as it continues to capitalize on Big Pharma' s looming market
problems?
- Patents have become a trapdoor for both Big Pharma and Mid Pharma alike;
once patents expire, these companies fi nd themselves hanging in a market
abyss. What methods are Specialty Pharma using to sidestep such patent expiry
pitfalls? What specifi c markets or patient cohorts are receiving attention
from Specialty Pharma?
- Value-for-money is the mantra of today' s knowledgeable and organized
health care customers-a challenge for Specialty Pharma, which has received
condemnation over its pricing of orphan drugs. How can Specialty Pharma
best present its pricing practices to an increasingly informed and skeptical
consumer audience?
Scope
- Market drivers: business factors and issues that are driving the
transformation of the pharma market.
- Market overview: market conditions that contributed to the emergence and
subsequent growth of Specialty Pharma.
- Success and uncertainty: how Specialty Pharma' s success has altered its
market space, and how these companies need to respond to the changing
marketplace.
- Specialty Pharma business models: 11 business models, with examples of
companies that utilize them.
- Challenges: threats to the continued growth of the Specialty Pharma sector.
- Market outlook: opportunities and strategies for Specialty Pharma
companies to succeed in today' s changing pharma business environment.
| 
View Cart
